Ключевые слова:
O‘SOK 2-turdagi diabet 1-3 bosqichdagi surunkali buyrak yetishmovchiligi.Библиографические ссылки
Bakker H, Jaddoe VW. Cardiovascular and metabolic influences of fetal smoke exposure.// Eur J Epidemiol. 2011 Oct;26(10):763-70. doi: 10.1007/ s10654-011-9621-2.
Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, Speizer FE. Cigarette smoking and the risk of diabetes in women. //Am J Public Health. 1993 Feb;83(2):211-4. doi: 10.2105/ajph.83.2.211.
Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. //Chest. 2007 May;131(5):1557-66. doi: 10.1378/chest.06-2179.
van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. //Physiol Rev. 2011 Jan;91(1):79-118. doi: 10.1152/physrev.00003.2010.
Matthews DR, Matthews PC. Banting Memorial Lecture 2010^. Type 2 diabetes as an 'infectious' disease: is this the Black Death of the 21st century? //Diabet Med. 2011 Jan;28(1):2-9. doi: 10.1111/j.1464-5491.2010.03167.x.
Tayal D, Jain P, Bhardwaj M, Sharma A. Diabetes mellitus in acute exacerbation of chronic obstructive pulmonary disease - the tip of the iceberg. //Monaldi Arch Chest Dis. 2024 Dec 31;94(4). doi: 10.4081/monaldi.2023.2776
Lonergan M, Dicker AJ, Crichton ML, Keir HR, Van Dyke MK, Mullerova H, Miller BE, Tal-Singer R, Chalmers JD. Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD. //Respir Res. 2020 Jul 1;21(1):166. doi: 10.1186/s12931-020-01436-7.
Huang J, Zeng T, Tian Y, Wu Y, Yu J, Pei Z, Tan L. Clinical significance of high-mobility group box-1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD). //J Clin Lab Anal. 2019 Jul;33(6):e22910. doi: 10.1002/jcla.22910.
Mattila T, Vasankari T, Rissanen H, Knekt P, Puukka P, Heliövaara M. Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period. //Eur J Epidemiol. 2018 Jan;33(1):89-98. doi: 10.1007/s10654-017-0278-3.
Cui J, Li G, Zhang M, Xu J, Qi H, Ji W, Wu F, Zhang Y, Jiang F, Hu Y, Zhang W, Wei X, Manza P, Volkow ND, Gao X, Wang GJ, Zhang Y. Associations between body mass index, sleep-disordered breathing, brain structure, and behavior in healthy children. //Cereb Cortex. 2023 Sep 9;33(18):10087-10097. doi: 10.1093/cercor/bhad267
Hamjane N, Benyahya F, Nourouti NG, Mechita MB, Barakat A. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review. //Microvasc Res. 2020 Sep;131:104 023. doi: 10.1016/j.mvr.2020.104023.
Yang Y. M. et al. The role of serum leptin and tumor necrosis factor-α in malnutrition of male chronic obstructive pulmonary disease patients //Chinese medical journal. – 2006. – Т. 119. – №. 8. – С. 628-633.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. // JAMA. 2001 Jul 18;286(3):327-34. doi: 10.1001/jama.286. 3.327.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. //N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.
Zewari S, Hadi L, van den Elshout F, Dekhuijzen R, Heijdra Y, Vos P. Obesity in COPD: Comorbidities with Practical Consequences? // COPD. 2018 Oct;15(5):464-471. doi: 10.1080/15412 555.2018.1509951.
Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. //Thorax. 2004 Jul;59 (7):574-80. doi: 10.1136/thx.2003.019588.